Moinzadeh P, Hunzelmann N, & Krieg T. (2013). Pharmacology and rationale for imatinib in the treatment of scleroderma. Dove Medical Press.
Chicago Style (17th ed.) CitationMoinzadeh P, Hunzelmann N, and Krieg T. Pharmacology and Rationale for Imatinib in the Treatment of Scleroderma. Dove Medical Press, 2013.
MLA (9th ed.) CitationMoinzadeh P, et al. Pharmacology and Rationale for Imatinib in the Treatment of Scleroderma. Dove Medical Press, 2013.
Warning: These citations may not always be 100% accurate.